Detection of Streptococcus pyogenes by use of Illumigene group a streptococcus assay

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4207-4209

  Henson, Amanda M ^a,b   Carter, Donna ^a   Todd, Kathleen ^a   Shulman, Stanford T ^a,c   Zheng, Xiaotian ^a,c  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b RUSH UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ANTIGEN DETECTION; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BIOASSAY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENE AMPLIFICATION; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; THROAT CULTURE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; HUMANS; INFANT; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; PHARYNX; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TIME FACTORS; YOUNG ADULT;

EID: 84889869548     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01892-13     Document Type: Article

References (21)

1. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. 2012. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 55:1279-1282.
2. Garcia LS, Isenberg HD. 2007. Group A Streptococcus: culture and nonculture tests, p 3.11.8.1-3.11.8.7. In Garcia LS, Isenberg HD (ed), Clinical microbiology procedures handbook, 3rd ed.ASMPress, Washington, DC
3. Billal DS, Hotomi M, Shimada J, Fujihara K, Ubukata K, Sugita R, Yamanaka N. 2008. Prevalence of Streptococcus invasive locus (sil) and its relationship with macrolide resistance among group A Streptococcus strains. J. Clin. Microbiol. 46:1563-1564.
4. Jing HB, Ning BA, Hao HJ, Zheng YL, Chang D, Jiang W, Jiang YQ. 2006. Epidemiological analysis of group A streptococci recovered from patients in China. J. Med. Microbiol. 55:1101-1107.
5. CLSI. 2011. Performance standards for antimicrobial susceptibility testing: 21st informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Uhl JR, Adamson SC, Vetter EA, Schleck CD, Harmsen WS, Iverson LK, Santrach PJ, Henry NK, Cockerill FR. 2003. Comparison of Light- Cycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs. J. Clin. Microbiol. 41:242-249.
7. Lalande V, Barrault L, Wadel S, Eckert C, Petit J, Barbut F. 2011. Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections. J. Clin. Microbiol. 49:2714-2716.
8. Doing KM, Hintz MS. 2012. Prospective evaluation of the Meridian Illumigene loop-mediated amplification assay and the Gen Probe Pro- Gastro Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile. Diagn. Microbiol. Infect. Dis. 72:8-13.
9. Boyanton BL, Sural P, Loomis C, Pesta C, Gonzalez-Krellwitz L, Robinson- Dunn B, Riska P. 2012. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection. J. Clin. Microbiol. 50:640-645.
10. Slinger R, Goldfarb D, Rajakumar D, Moldovan I, Barrowman N, Tam R, Chan F. 2011. Rapid PCR detection of group A streptococcus from flocked throat swabs: a retrospective clinical study. Ann. Clin. Microbiol. Antimicrob. 10:33. doi:10.1186/1476-0711-10-33.
11. Anderson NW, Buchan BW, Mayne D, Mortensen JE, Mackey TA, Ledeboer NA. 2013. Multicenter clinical evaluation of the illumigene group A Streptococcus DNA amplification assay for detection of group A Streptococcus from pharyngeal swabs. J. Clin. Microbiol. 51:1474-1477.
12. Green TA, Black CM, Johnson RE. 1998. Evaluation of bias in diagnostictest sensitivity and specificity estimates computed by discrepant analysis. J. Clin. Microbiol. 36:375-381.
13. McAdam AJ. 2000. Discrepant analysis: how can we test a test? J. Clin. Microbiol. 38:2027-2029.
14. Hadgu A. 2000. Discrepant analysis is an inappropriate and unscientific method. J. Clin. Microbiol. 38:4301-4302.
15. Sternberg M. 2001. Discrepant analysis is still at large. J. Clin. Microbiol. 39:826-827.
16. Tanz RR, Shulman ST, Shortridge VD, Kabat W, Kabat K, Cederlund E, Rippe J, Beyer J, Doktor S, Beal BW, North American Streptococcal Pharyngitis Surveillance Group. 2004. Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin. Infect. Dis. 39: 1794-1801.
17. Bley C, van der Linden M, Reinert RR. 2011. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany. Int. J. Antimicrob. Agents 37:425-431.
18. Rubio-Lopez V, Valdezate S, Alvarez D, Villalon P, Medina MJ, Salcedo C, Saez-Neito J. 2012. Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994 -2006).BMCMicrobiol. 12:215. doi:10.1186/1471-2180-12-215.
19. Liang Y, Liu X, Chang H, Ji L, Huang G, Fu Z, Zheng Y, Wang L, Li C, Shen Y, Yu S, Yao K, Ma L, Shen X, Yang Y. 2012. Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. J. Med. Microbiol. 61:975-983.
20. Yang P, Peng X, Zhang D, Wu S, Liu Y, Cui S, Lu G, Duan W, Shi W, Liu S, Li J, Wang Q. 2013. Group A Streptococcus strains circulating during scarlet fever epidemic, Beijing, China, 2011. Emerg. Infect. Dis. 19:909-915.
21. Yan SS, Fox ML, Holland SM, Stock F, Gill VI, Fedorko DP. 2000. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob. Agents Chemother. 44: 3196-3198.